TickerFactsScreenerDevelopers

Amphastar Pharmaceuticals, Inc. (AMPH) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $53.74M2012: $50.21M2013: $53.59M2014: $67.83M2015: $66.07M2016: $72.35M2017: $65.59M2018: $86.34M2019: $73.69M2020: $92.64M2021: $126.35M2022: $156.10M2023: $144.30M2024: $151.61M2025: $170.18M$170.18M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$170.18M+12.2%
2024$151.61M+5.1%
2023$144.30M-7.6%
2022$156.10M+23.5%
2021$126.35M+36.4%
2020$92.64M+25.7%
2019$73.69M-14.7%
2018$86.34M+31.6%
2017$65.59M-9.3%
2016$72.35M+9.5%
2015$66.07M-2.6%
2014$67.83M+26.6%
2013$53.59M+6.7%
2012$50.21M-6.6%
2011$53.74M—